Oral formulation for twice-daily administration

The invention relates to an oral drug which should be taken two times one day, wherein it is characterized in that: it comprises: L-cysteamine or its salt, and ascorbic acid or its salt; one-time drug supply of L- cysteamine is 90-150mg; and it can treat color sink disease caused by ephelis.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	KURAZUMI TOSHIAKI, ONUKI YOICHI, OKADA MINORU, OTAKI HIROSHI
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention relates to an oral drug which should be taken two times one day, wherein it is characterized in that: it comprises: L-cysteamine or its salt, and ascorbic acid or its salt; one-time drug supply of L- cysteamine is 90-150mg; and it can treat color sink disease caused by ephelis.